ライフサイエンスコーパス: pleural effusion

1 PEL, which arises in a hypoxic environment (pleural effusions).

2 nical characters, such as refractoriness and pleural effusion.

3 peutic strategy for the control of malignant pleural effusion.

4 e II (n = 88) studies for the development of pleural effusion.

5 schedule may result in a higher incidence of pleural effusion.

6 patient irritability, small pericardial +/- pleural effusion.

7 o be secondary to a decrease or absence of a pleural effusion.

8 they showed any mismatched V/Q defect or any pleural effusion.

9 l or reticulonodular pattern with or without pleural effusion.

10 graphy for PE with radiographic evidence for pleural effusion.

11 t upper lobe mass along with a moderate-size pleural effusion.

12 diffuse interstitial pattern with or without pleural effusion.

13 owed mild pulmonary edema with a small right pleural effusion.

14 rentially diagnose tuberculous and malignant pleural effusion.

15 aphy showed an enlarged heart with bilateral pleural effusion.

16 ostoperative AF or postoperative pericardial/pleural effusion.

17 nts were postoperative AF and pericardial or pleural effusion.

18 esis is performed to identify the cause of a pleural effusion.

19 ractory MPP children or in MPP children with pleural effusion.

20 s. 19+/-6 bpm, p<0.01) than those with lower pleural effusion.

21 anulomas as well as ascites and a left-sided pleural effusion.

22 tein, release of inflammatory cytokines, and pleural effusion.

23 xudative pleural effusions from transudative pleural effusions.

24 cy and the presence, size, and laterality of pleural effusions.

25 e may reduce the incidence of pneumonia with pleural effusions.

26 ed as factors associated with development of pleural effusions.

27 s Fontan morbidity, particularly duration of pleural effusions.

28 ain the prominent and persistent hemorrhagic pleural effusions.

29 ne, it induced transient production of large pleural effusions.

30 ty, thickened bronchial walls, and bilateral pleural effusions.

31 loped low cardiac output, and 3 patients had pleural effusions.

32 rodesis was successful in treating malignant pleural effusions.

33 evaluated; (c) unsuspected pneumonia; or (d) pleural effusions.

34 lycans mimicked the inhibition observed with pleural effusions.

35 hymal opacities, cavitation, adenopathy, and pleural effusions.

36 onventional inpatient treatment of malignant pleural effusions.

37 all thickening, nodules, Kerley B lines, and pleural effusions.

38 eft pulmonary artery thrombosis, and chronic pleural effusions.

39 ntional T2-weighted sequences revealed small pleural effusions.

40 airment were more likely to have significant pleural effusions.

41 PCs (13.2% vs 40.5%, P < 0.001), symptomatic pleural effusion (11.6% vs 26.4%, P = 0.003), pleural ef

42 -up data were available for 31 of 39 treated pleural effusions: 11 (35%) had CR, 18 (58%) had PR, and

43 ), thoracic duct dilatation (4% vs 0, P=.3), pleural effusion (12% vs 6%, P=.2), or ascites (10% vs 6

44 (20%), intrathoracic lymphadenopathy (16%), pleural effusion (12%), reticular infiltration (4%), and

45 Interstitial opacities (6%) and pleural effusions (12%) were uncommon.

46 ophic scar formation (35), atelectasis (12), pleural effusion (13), recurrent sternal depression (5),

47 %), oral ulcers (24.2%), joint pain (23.0%), pleural effusion (16.5%) and increase in abdominal girth

48 rapy was most effective in the resolution of pleural effusions (2 of 2), ascites (6 of 8), and hydrop

49 opathy (23%), mass-like consolidation (17%), pleural effusion (8.6%), and honey combing (5.7%).

50 Significant pleural effusions after the Fontan operation prolong hos

51 tients in the once-daily group experienced a pleural effusion (all grades, 20% vs 39% P < .001).

52 ily resulted in significantly lower rates of pleural effusion (all grades, 7% v 16%; P = .024) and gr

53 y-proven PE, 77 (47%) had at least one large pleural effusion and 86 (53%) had a small effusion; 33 (

54 ome features was strong (eg, alpha = .78 for pleural effusion and ascites) but was lower for others (

55 ded the use of ultrasonography for ruling-in pleural effusion and assisting its drainage, ascites dra

56 ersistent fever caused by pneumonia (n = 2), pleural effusion and atelectasis (n = 1), or liver absce

57 adiologically as interstitial pneumonia with pleural effusion and clinically as hypoxemic respiratory

58 CAP with pleural effusion and documented pneumococcal CAP were di

59 th dasatinib compared with imatinib, whereas pleural effusion and grade 3/4 thrombocytopenia were mor

60 ion in lung injury, as assessed by volume of pleural effusion and histological analyses (significant

61 When pleural effusion and intra-abdominal hypertension were s

62 Among patients with malignant pleural effusion and no previous pleurodesis, there was

63 unrelated to alectinib: acute renal failure; pleural effusion and pericardial effusion; and brain met

64 r talc slurry in the management of recurrent pleural effusion and pneumothorax.

65 urs in mouse models of malignant lung cancer pleural effusion and spontaneous colon cancer metastasis

66 lations of leukocytes and malignant cells in pleural effusions and accurately predict disease state i

67 In both groups, pleural effusions and air bronchograms are common, and K

68 Two patients, including one with large pleural effusions and another with ventricular tachycard

69 n of peritoneal spread, presence and size of pleural effusions and ascites, lymphadenopathy, and dist

70 renchyma, which is sometimes associated with pleural effusions and diffuse alveolar hemorrhage.

71 nt has altered the traditional management of pleural effusions and empyema in children, resulting in

72 tered to improve the drainage of complicated pleural effusions and empyemas and it is the most effect

73 Prominent serosanguinous pleural effusions and hemorrhagic mediastinitis were fou

74 hy of the chest demonstrated large bilateral pleural effusions and hemorrhagic mediastinitis.

75 ared to be related to significant, prolonged pleural effusions and longer hospitalizations.

76 gnificantly post antibiotic treatment in the pleural effusions and pleural macrophages up-regulated m

77 by progression of respiratory insufficiency, pleural effusions and pulmonary edema, and, ultimately,

78 s observed, in the other one, pneumonia with pleural effusion, and as a consequence of inflammatory i

79 primary tumor, pleural metastases, malignant pleural effusion, and ascites obtained during disease pr

80 arch for thickening of the gallbladder wall, pleural effusion, and ascites.

81 ata suggest a strong impact of PCV13 on CAP, pleural effusion, and documented pneumococcal pneumonia,

82 cul-de-sac, peritoneal implants, ipsilateral pleural effusion, and intratumoral hemorrhage.

83 Reported events included seizure, pleural effusion, and lymphocytopenia.

84 sults suggest that drainage of the malignant pleural effusion, and perhaps enzymatic pretreatment of

85 pic support, thoracostomy tube drainage of a pleural effusion, and prolonged antimicrobial therapy.

86 ts and included disease progression, anemia, pleural effusion, and thrombocytopenia.

87 required no further treatment), two cases of pleural effusion, and two cases of moderate pain (one ca

88 on with tamponade associated with pneumonia, pleural effusion, and urinary tract infection.

89 y, and most animals also developed leukemia, pleural effusion, and, in some cases, ascites associated

90 monstrated mediastinal widening, adenopathy, pleural effusions, and air-space disease.

91 norexia, and nausea), skin rash, cytopenias, pleural effusions, and fatigue.

92 samples (tumor and normal pleura), malignant pleural effusions, and in established mesothelioma cell

93 of thiourea, W/D increased to 5.5 and marked pleural effusions appeared, but there were no difference

94 Hemorrhage and pleural effusion are prominent pathological features of

95 Over 200000 pleural effusions are attributable to cancer in the UK a

96 Pleural effusions are common in candidates for heart, li

97 heir presence in urine, chylous ascites, and pleural effusions are consistent with their ability to m

98 Pleural effusions are expected sequelae after lung trans

99 ts corresponding to radiographically-evident pleural effusions are of intermediate probability for PE

100 nvolvement-thoracic duct dilatation, chylous pleural effusion, ascites, and LALM-is more common in LA

101 that increased gall bladder wall thickness, pleural effusion, ascites, hepatomegaly, and splenomegal

102 ngs included enlarged abdominal lymph nodes, pleural effusions, ascites, and dilatation of the thorac

103 estigated the risk factors and management of pleural effusion associated with dasatinib therapy for c

104 sion may be instrumental to the treatment of pleural effusion-associated lung restriction and cyclica

105 was designed to determine the prevalence of pleural effusion at approximately 28 days after cardiac

106 ion, but 1 patient developed pericardial and pleural effusion attributed to pericardial instrumentati

107 The presence of a pleural effusion before dasatanib therapy predicted the

108 liphatic analogues toward MCF-7 cells (human pleural effusion breast adenocarcinoma cell line).

109 Lung congestion and pericardial and pleural effusions can cause attenuation in the ECG poten

110 rom 41.3% to 29.7% (P < .001), the number of pleural effusion cases decreased by 53% (167 to 79; P <

111 e believe that this is the first report of a pleural effusion caused by HSV II, and suggest that this

112 Pleural effusions caused by herpes simplex viruses are r

113 Malignant pleural effusion causes disabling dyspnea in patients wi

114 RNA from pleural effusion cells was examined to determine TGF-bet

115 ntestinal and/or pulmonary lymphangiectasia, pleural effusions, chylothoraces and/or pericardial effu

116 Chylous pleural effusion (chylothorax) frequently accompanies ly

117 Those with CNS disease, pleural effusion, circulating lymphoma cells > or = 5,00

118 -2.2% to 17.6%) or postoperative pericardial/pleural effusion (colchicine, 103 patients [57.2%]; plac

119 phosphorylation in MT cells, derived from a pleural effusion, compared with cells from the primary t

120 adiograph revealed hilar adenopathy and left pleural effusion; computed tomography scan showed a 2-cm

121 s predictive of CT outcome, although lack of pleural effusion correlated with clinical stability.

122 investigated whether fibulin-3 in plasma and pleural effusions could meet sensitivity and specificity

123 In cytology-negative suspected malignant pleural effusions, CT-guided pleural biopsy is a better

124 Among patients with malignant pleural effusion, daily drainage of pleural fluid via an

125 Pericardial and pleural effusions developed in one patient after cycles

126 ever, higher morbidity of tachypnea/dyspnea, pleural effusion, diarrhea, hepatosplenomegaly, consciou

127 )CD16(-) NK cells isolated from inflammatory pleural effusions display a potent regulatory activity.

128 to improve overall survival in patients with pleural effusion due to malignant pleural mesothelioma,

129 tasis have a history of asbestos exposure or pleural effusion due to various causes.

130 ion defect(s), and (g) perfusion defect from pleural effusion equal to one third or more of the pleur

131 ential diagnosis of an unexplained exudative pleural effusion, especially in an immunocompromised hos

132 2S protein were observed in seven of 17 lung pleural effusion fluids of lung cancer patients.

133 es vascular permeability and is important in pleural effusion formation.

134 s immunosuppressive therapy, who had a large pleural effusion, found on a chest radiograph during the

135 nd primary cultures, as well as in a primary pleural effusion from a breast cancer patient.

136 Organ-specific pleural complications include pleural effusion from hepatic venoocclusive disease, spo

137 after bone marrow transplantation, and early pleural effusion from urinothorax and late effusion from

138 d we also detected CXCL12-gamma in malignant pleural effusions from patients with breast cancer.

139 values can help in differentiating exudative pleural effusions from transudative pleural effusions.

140 -172 mL vs. 80+/-87 mL, p<0.0001, for higher pleural effusion group vs. lower pleural effusion group)

141 /-124 mL vs. 23+/-29 mL, p<0.0001 for higher pleural effusion group vs. lower pleural effusion group,

142 for higher pleural effusion group vs. lower pleural effusion group) was greater than the estimated l

143 for higher pleural effusion group vs. lower pleural effusion group, respectively).

144 Patients were divided into higher and lower pleural effusion groups according to the median value (2

145 s following induction of an antigen-specific pleural effusion, guinea pigs were injected intrapleural

146 RATIONALE: Patients with malignant pleural effusions have significant dyspnea and shortened

147 DLT in later courses included pleural effusions, hemangiomatosis, and GI hemorrhage.

148 ommonly seen pulmonary complications include pleural effusion, hemothorax, atelectasis, pulmonary ede

149 n 480 (39.5%) patients including symptomatic pleural effusion in 366 (30.1%) patients, respiratory in

150 63 patients, CT demonstrated an increase in pleural effusion in 46 (73%), periaortic changes in 21 (

151 d JIMT-1 breast cancer cells, derived from a pleural effusion in a patient who displayed clinical res

152 Pleural effusion in acute lung injury or acute respirato

153 To assess the effects of pleural effusion in patients with acute lung injury on l

154 ions in 13 group A versus 4 group B fetuses, pleural effusions in 2 group A versus 0 group B, ascites

155 Readers 1 and 2 found pleural effusions in 40 and 41 stage III and 20 and 21 s

156 Small-bore catheter drainage of persistent pleural effusions in lung transplant recipients is usual

157 The prevalence of pleural effusions in the patients undergoing only CABG s

158 sion defects and elimination of lungs with a pleural effusion indicate that triple matches with PE (r

159 -expiratory pressure 10 benefit in reversing pleural effusion-induced de-recruitment.

160 Unilateral pleural effusion instillation (13 mL/kg), intra-abdomina

161 s a primary target organ with serosanguinous pleural effusions, intra-alveolar edema, and hemorrhagic

162 al hypertension (15 mm Hg), and simultaneous pleural effusion/intra abdominal hypertension.

163 analysis revealed that histology, malignant pleural effusion, intraparenchymal liver metastasis, and

164 Pleural effusion is a frequent finding in patients with

165 Treatment of symptomatic carcinomatous pleural effusions is primarily directed at local palliat

166 areas of consolidation, areas of cavitation, pleural effusions, linear opacities, septal thickening,

167 Proliferative responses of pleural effusion lymphocytes were examined in response t

168 ned as a stable episome in latently infected pleural effusion lymphoma (PEL) cells.

169 and host-cell genomes of a latently infected pleural effusion lymphoma cell line BCBL1.

170 In pleural effusion lymphoma cell lines that express variab

171 s constitutively expressed in HHV-8-positive pleural effusion lymphoma cell lines.

172 rantly accumulated in latently KSHV-infected pleural effusion lymphoma cells and results in increased

173 transcription in the latently infected BCBL1 pleural effusion lymphoma-derived cell line.

174 svirus 8 (HHV-8) causes Kaposi's sarcoma and pleural effusion lymphoma.

175 ecreased intracellular bacterial survival in pleural-effusion macrophages of the guinea pigs infected

176 Large pleural effusions may develop in a small proportion of p

177 The lymphoma presented with pleural effusions, mediastinal and cervical adenopathy,

178 Malignant pleural effusion (MPE) is the lethal consequence of vari

179 Malignant pleural effusion (MPE) poses a significant clinical prob

180 us pleural effusion (TPE, n = 50), malignant pleural effusion (MPE, n = 41), other cases including pn

181 quantified MCs in human and murine malignant pleural effusions (MPEs) and evaluated the fate and func

182 revealed a globular dilated heart, bilateral pleural effusions, myocyte apoptosis, and transmural myo

183 areas of hazy increased attenuation (n = 1), pleural effusion (n = 1), and areas of cavitation (n = 1

184 e included patients with pneumonia (n = 28), pleural effusion (n = 13), pleural empyema (n = 4), lung

185 l thickening (n = 7), consolidation (n = 5), pleural effusion (n = 4), and solitary endobronchial les

186 onal lymph node invasion (n = 8), ascites or pleural effusion (n = 7), and metastases to liver (n = 5

187 Complications included pleural effusion (n = 7), pneumothorax (n = 2), pericard

188 Adverse events included procedure-related pleural effusion (n=2), cholecystitis (n=1), and additio

189 For treatment of malignant pleural effusion, nonsteroidal anti-inflammatory drugs (

190 Perfusion defects associated with small pleural effusions (obliteration of the costophrenic angl

191 In conclusion, the prevalence of pleural effusions occupying more than 25% of the hemitho

192 Pleural effusions occur during dasatinib therapy, partic

193 Pleural effusion occurred in 27% of patients (grade 3 to

194 Pleural effusion occurred in 48 patients (35%; grade 3/4

195 One case of thrombosis and one case of pleural effusion occurred.

196 mouse xenograft (Sparky-X) from a malignant pleural effusion of a 12-year-old Persian male with auto

197 a population established in culture from the pleural effusion of a breast cancer patient showed disti

198 Pulmonary emboli are associated with pleural effusions of all sizes.

199 cancer cell lines in vitro, or isolated from pleural effusions of mesothelioma patients triggered dow

200 els of activity were seen with exosomes from pleural effusions of mesothelioma patients.

201 Cells isolated from ascites or pleural effusions of patients with metastatic breast can

202 ictor of anthrax was mediastinal widening or pleural effusion on a chest radiograph.

203 re (HR, 2.55; 95% CI, 1.15 to 5.63; P=0.02), pleural effusion on chest radiograph (HR, 2.56; 95% CI,

204 lking status, and ascites, moderate-to-large pleural effusion on CT images was significantly associat

205 reasing periaortic hematoma, and hemorrhagic pleural effusion on imaging identify patients with compl

206 Moderate-to-large pleural effusion on preoperative CT images in patients w

207 hematocrit <30% (OR, 2.0; 95% CI, 1.3-3.2), pleural effusion on presenting chest x-ray (OR, 1.6; 95%

208 L/One hundred and twenty eight patients with pleural effusions on thoracic CT who underwent thoracent

209 hospital admissions for bronchitis (one) and pleural effusion (one), grade 3 increase in aminotransfe

210 Methods Patients with NSCLC (stage IIIB with pleural effusion or stage IV according to American Joint

211 Patients with stage IIIB NSCLC with pleural effusion or stage IV NSCLC, who had Eastern Coop

212 l of patients with advanced (stage IIIB with pleural effusion or stage IV) non-small-cell lung cancer

213 Patients with stage IIIB (with pleural effusion or supraclavicular nodes) to IV NSCLC a

214 Radiographs were assessed for presence of pleural effusions or lymphadenopathy.

215 uce a pleurodesis in patients with recurrent pleural effusions or pneumothorax should be investigated

216 chemotherapy-naive patients with stage IIIB (pleural effusion) or IV NSCLC, without restrictions by h

217 chemotherapy-naive patients with stage IIIB (pleural effusion) or stage IV NSCLC of any histology or

218 her findings (mediastinal edema, adenopathy, pleural effusion, or a sternal or lung abnormality).

219 Nodular opacities, reticular opacities, pleural effusion, or lymphadenopathy were not observed i

220 Patients with stage IIIB disease with pleural effusion, or stage IV NSCLC and Eastern Cooperat

221 ned or recurrent pain (P<0.0001), increasing pleural effusion (P=0.0003), and both the maximum diamet

222 0.009), pulmonary hypertension (P < 0.001), pleural effusions (P = 0.01), myositis (P = 0.02), and a

223 that regulate the pathogenesis of malignant pleural effusion (PE) associated with advanced stage of

224 milar effect, achieving control of malignant pleural effusion (pleurodesis).

225 riables studied were the occurrence of PPCs, pleural effusion, pneumonia, and pulmonary embolism.

226 s (mediastinal bleeding, pneumothoraces, and pleural effusions), postdischarge complications, reopera

227 These larger pleural effusions produce dyspnea but not chest pain or

228 There were 4 independent risk factors for pleural effusion: prolonged surgery (OR = 1), surgery on

229 For dyspnea and malignant pleural effusions, providers should offer thoracentesis,

230 correlated significantly with the volume of pleural effusions (r = 0.79, p < 0.00001).

231 of confirmed or suspected mesothelioma with pleural effusion, recruited from 12 hospitals in the UK.

232 leural effusion (11.6% vs 26.4%, P = 0.003), pleural effusion requiring drainage (1.7% vs 9.9%, P = 0

233 = 49, 12%), incisional hernia (n = 22, 6%), pleural effusion requiring intervention (n = 21, 5%), ne

234 cantly (P<0.0001) associated with pneumonia, pleural effusions requiring drainage, and maximum postop

235 l gene transfer to cancer cells in malignant pleural effusions revealed that transduction was markedl

236 other signs (ie, halo sign, hypodense sign, pleural effusion, reversed halo sign) is unknown.

237 pted method for the treatment of symptomatic pleural effusions secondary to mesotheliomas.

238 HH is a transudative pleural effusion seen in 5%-10% of cirrhosis patients, i

239 none), dyspnoea (six [2%] vs one [1%]), and pleural effusion (six [2%] vs none).

240 cancer were thrombocytopenia (eight [11%]), pleural effusion (six [8%]), and increased lipase (five

241 This study was conducted to determine if pleural effusion size affects ventilation/perfusion (V/Q

242 l lung scan interpretive criteria based upon pleural effusion size is not warranted.

243 Bedside US can be used to detect a pleural effusion so well in critically ill patients that

244 Large pleural effusions sometimes occur after coronary artery

245 ine (SUM-52PE), originating from a malignant pleural effusion specimen, that can be cultured under se

246 assays and biochemical analyses of malignant pleural effusion specimens revealed CS in relevant conce

247 Subcutaneous edema, ascites, pleural effusion, splenomegaly, varices, portal venous t

248 ociations among themselves and with ascites, pleural effusions, subcutaneous edema, and low mean seru

249 ion of the heart, increased lung weight, and pleural effusion, suggesting that they died of congestiv

250 B but increased risk of rapid progression to pleural effusion TB.

251 Pleural effusions that occupied more than 25% of the hem

252 sed included noncalcified pulmonary nodules, pleural effusion, thoracic duct dilatation, hepatic and

253 the selected conditions ranged from 0.22 for pleural effusion to 0.0004 for tension pneumothorax.

254 ndwelling pleural catheter was placed in the pleural effusion to drain the fluid fully.

255 We enrolled 91 cases, including tuberculous pleural effusion (TPE, n = 50), malignant pleural effusi

256 ned in 31 lung transplant recipients who had pleural effusions treated with catheter drainage were re

257 , and information on pleural fluid findings, pleural effusion treatment, and cardiac surgery was obta

258 imary malignancy and a symptomatic malignant pleural effusion underwent small-bore-catheter thoracost

259 Pleural effusion volume was determined on each CT scan s

260 d causing medium lobe atelectasis; bilateral pleural effusion was also present.

261 Pleural effusion was an expected and problematic toxicit

262 Pneumococcal pneumonia with pleural effusion was associated with a limited number of

263 rsus 30%) were more prevalent with imatinib; pleural effusion was more common with dasatinib (17% ver

264 functional residual capacity by 368 mL when pleural effusion was present and by 184 mL when intra-ab

265 Pleural effusion was present at some point during the co

266 Pleural effusion was present on radiographs in seven pat

267 ents identified in either treatment arm, and pleural effusion was the only drug-related, nonhematolog

268 or absence of parenchymal abnormalities and pleural effusions was noted.

269 loss and septal thickening, with or without pleural effusion, was never seen in the absence of acute

270 us pneumoniae responsible for pneumonia with pleural effusion, we determined the capsular polysacchar

271 Among hospitalized patients with pleural effusions, we identified subgroup of patients in

272 Patients with higher pleural effusion were older (62+/-16 yr vs. 54+/-17 yr,

273 First occurrences of pleural effusion were reported with dasatinib, with the

274 Pleural effusions were classified as exudates or transud

275 Mediastinal adenopathy or pleural effusions were classified as typical of recent i

276 Orthotopic tumors and pleural effusions were clearly visualized at MR imaging

277 secutive patients with symptomatic malignant pleural effusions were enrolled.

278 tocytologically proven symptomatic malignant pleural effusions were included in this phase I toxicity

279 The incidence of pleural effusions were not significantly different betwe

280 Pleural effusions were present in one-half of the patien

281 h cytologically negative suspected malignant pleural effusions were recruited.

282 Pleural effusions were seen in 16 (57%) patients with PE

283 However, mediastinal adenopathy and pleural effusions were significantly more common in HIV-

284 Thirty three (26%) of the 128 pleural effusions were transudates and 95 (74%) were exu

285 and asthenia (40 [5%] vs 23 [3%]); grade 3-4 pleural effusions were uncommon (ten [1%] vs three [<1%]

286 er radiologic findings (multiple nodules and pleural effusion) were less frequent, but appeared later

287 nia in children is frequently complicated by pleural effusions, which rarely progress to empyema.

288 (1:1) for which 106 patients with malignant pleural effusion who had not previously undergone pleuro

289 The association of pleural effusion with other conditions mirrored that in

290 o of right to left lung mass, association of pleural effusion with other conditions, and frequency of

291 Larger doses of TGF-beta(2) induced larger pleural effusions with relatively low pleural fluid WBC

292 tomography (CT) findings for characterizing pleural effusions with the use of attenuation values.